curasan Stock Forecast for 2023 - 2025 - 2030
Updated on 05/01/2024
curasan Fair Value Forecast for 2023 - 2025 - 2030
In the last year, curasan's Price has seen an increase, rising from 0.00€ to 0.00€. This represents a growth of 100.00%. Analysts predict that curasan's Fair Value will increase in the upcoming year, reaching 0.00€. This would represent an increase of 100.00%. Over the next eight years, experts predict that curasan's Fair Value will grow at a rate of 100.00%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
MRK Stock Forecast | Merck KGaA | Outperform |
18
|
148.95€ | Buy/Sell | 190.06€ | 22.86% |
SAZ Stock Forecast | STADA Arzneimittel | - |
16
|
0.00€ | Buy/Sell | 0.00€ | 0.00% |
DMP Stock Forecast | Dermapharm Holding | Buy |
18
|
31.40€ | Buy/Sell | 56.75€ | 84.71% |
ATAI Stock Forecast | Atai Life Sciences N.V. | Buy |
3
|
$2.05 | Buy/Sell | $12.62 | 436.59% |
93M1 Stock Forecast | MPH Health Care | Outperform |
10
|
20.40€ | Buy/Sell | 65.80€ | 203.92% |
curasan EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last year, curasan's EPS has seen an increase, rising from 0.00€ to 0.00€. This represents a growth of 100.00%. Analysts predict that curasan's EPS will increase in the upcoming year, reaching 0.00€. This would represent an increase of 100.00%. Over the next eight years, experts predict that curasan's EPS will grow at a rate of 100.00%.